Analysis of these xenograft tumors 27-34 days after treatment showed a significant accumulation of human CD3 expressing GPA33-CAR T cells surrounding the tumor margin and partially infiltrating tumor epithelia (Fig. 5B, C). This evidence concerns the gene GPA33 and neoplasm.